According to the ASC Bylaws:
The general managment of the American Society of Cytopathology, including approval of the annual budget, shall be vested in the Executive Board. It shall regularly perform the ordinary duties of a board of directors to appoint any Committee it may deem necessary and to delegate whatever powers necessary to such Committees.
Executive Board Members are elected to serve a four-year term on the Board. Board Members are expected to regularly attend Board meetings, to exercise the diligence, review reports and issues with extreme care and question policy and procedures as though they were owners of the corporation.
Hormoz Ehya, M.D.
Nancy A. Young, M.D.
Lydia P. Howell, M.D.
Edmund S. Cibas, M.D.
Executive Board Members:
|Syed Z. Ali, M.D.
The Johns Hopkins Hospital
|Raheela Ashfaq, M.D.
University of Texas Southwestern
|Joel S. Bentz, M.D.
Laboratory Medicine Consultants, Ltd.
Las Vegas, NV
|Leigh Ann Cahill, B.S., CT(ASCP)
Medical College of Virginia
|Jill L. Caudill, M.Ed., SCT(ASCP)CM
Mayo School of Health-Related Sciences
|Terence J. Colgan, M.D.
Mount Sinai Hospital
Toronto, Ontario, Canada
|William N. Crabtree, Ph.D., SCT(ASCP)
Indiana University School of Medicine
|Ruth L. Katz, M.D.
M.D. Anderson Cancer Center
|Ritu Nayar, M.D.
Northwestern Memorial Hospital
|Andrew A. Renshaw, M.D.
Baptist Hospital of Miami
| Donna K. Russell, M.S., CT(ASCP)HT
University of Rochester Medical Center
|Eva M. Wojcik, M.D., MIAC
Loyola University Medical Center
Ann T. Moriarty, M.D.